Jiaxing-based Zhejiang Taimei Medical Technology Co Ltd gets listed on the Hong Kong Stock Exchange. [Photo/WeChat account: jxfabu]

Following its inclusion on the Hong Kong Stock Exchange, Zhejiang Taimei Medical Technology Co Ltd just became the first Jiaxing company this year to be listed internationally. Jiaxing now boasts 88 listed companies, ranking third in Zhejiang province.

Founded in 2013, Taimei Medical focused on pharmaceutical R&D software before transitioning in 2019 to provide integrated digital solutions for the pharmaceutical and medical device industries. This innovation attracted significant investment, turning Taimei Medical into a celebrated unicorn.

Taimei Medical offers specialized software and digital services for the life sciences sector, and in 2022, became China's largest digital solutions provider in this field.

The company's key platforms, TrialOS and PharmaOS, connect stakeholders like hospitals, pharmaceutical companies, and regulators, enhancing efficiency in drug and device development.

With on-hand orders valued at 1.6 billion yuan ($224.73 million) as of Sept 30, 2023, Taimei Medical covers over 3,300 projects. In 2022, its core customer retention rate reached 94.7 percent.

The number of listed companies in Jiaxing has expanded to 88. This year marks a historic achievement, with two Jiaxing companies' annual revenue exceeding 100 billion yuan. Additionally, six Jiaxing-based companies made it onto the 2024 list of China's Top 500 Enterprises.